Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.49 (Beat by $0.02) |
EPS GAAP Actual | $0.49 (Beat by $0.02) |
Revenue Actual | $0.9104B |
Revenue Surprise | Beat by $910.4M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.49 |
EPS GAAP Estimate | $2.49 |
Revenue Estimate | $1.0499B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.99 | 8.46 | 4.84316 | 5.14222 | 1 |
Dec 2028 | 7.77 | 5.43 | 7.73452 | 7.80548 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.49 | 0.49 | 0.9104B | -16.05% | 910.4M |
FQ4 2024 (Dec 2024) | 0.59 | 0.59 | 1.0675B | 3.78% | 1067.5M |
FQ3 2024 (Sep 2024) | 0.98 | 0.98 | 1.0161B | 1.47% | 1016.1M |
FQ2 2024 (Jun 2024) | 3.62 | 3.62 | 1.1681B | 6.63% | 1168.1M |
FQ1 2024 (Mar 2024) | 2.97 | 2.97 | 1.0565B | 5.41% | 1056.5M |
FQ4 2023 (Dec 2023) | 1.47 | 1.47 | 1.0272B | 4.09% | 1027.2M |
FQ3 2023 (Sep 2023) | 2.08 | 2.08 | 1.0012B | 16.09% | 1001.2M |
FQ2 2023 (Jun 2023) | 2.23 | 2.23 | 1.0906B | 100% | 1090.6M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.49
Consensus Revenue Estimates
1.0499B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 1.66 | -- | 1.56894 | 1.75106 | 1 |
FQ3 2027 (Jul 2027) | 2.1 | -- | 2.02097 | 2.17903 | 0 |
FQ2 2027 (Jun 2027) | 2.1 | -- | 2.03976 | 2.16024 | 0 |
FQ1 2027 (Mar 2027) | 2.36 | -- | 2.2923 | 2.4277 | 0 |
FQ4 2026 (Oct 2026) | 2.73 | -- | 2.62726 | 2.83274 | 0 |
FQ3 2026 (Jul 2026) | 2.38 | -- | 2.29043 | 2.46957 | 0 |
FQ2 2026 (Jun 2026) | 2.38 | -- | 2.31172 | 2.44828 | 0 |
FQ1 2026 (Mar 2026) | 2.14 | 77.1 | 2.07861 | 2.20139 | 0 |
FQ4 2025 (Oct 2025) | 2.49 | 76.31 | 2.39629 | 2.58371 | 0 |
FQ3 2025 (Sep 2025) | 2.49 | 60.64 | 2.41857 | 2.56143 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 1.21B | -- | 1.16B | 1.26B | 1 |
FQ3 2027 (Jul 2027) | 1.23B | -- | 1.19B | 1.27B | 1 |
FQ2 2027 (Jun 2027) | 1.23B | -- | 1.2B | 1.26B | 1 |
FQ1 2027 (Mar 2027) | 1.16B | -- | 1.13B | 1.18B | 1 |
FQ4 2026 (Oct 2026) | 1.14B | -- | 1.11B | 1.18B | 1 |
FQ3 2026 (Jul 2026) | 1.11B | -- | 1.08B | 1.14B | 1 |
FQ2 2026 (Jun 2026) | 1.11B | -- | 1.08B | 1.13B | 1 |
FQ1 2026 (Mar 2026) | 1.08B | 15.34 | 1.05B | 1.1B | 1 |
FQ4 2025 (Oct 2025) | 1.05B | -1.68 | 1.02B | 1.08B | 0 |
FQ3 2025 (Sep 2025) | 1.05B | 3.22 | 1.03B | 1.07B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.49 | 0.49 | 100% | |
FQ4 2024 (Dec 2024) | 0.59 | 0.59 | 100% | |
FQ3 2024 (Sep 2024) | 0.98 | 0.98 | 100% | |
FQ2 2024 (Jun 2024) | 3.62 | 3.62 | 100% | |
FQ1 2024 (Mar 2024) | 2.97 | 2.97 | 100% | |
FQ4 2023 (Dec 2023) | 1.47 | 1.47 | 100% | |
FQ3 2023 (Sep 2023) | 2.08 | 2.08 | 100% | |
FQ2 2023 (Jun 2023) | 2.23 | 2.23 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.91B | $910.4M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.07B | $1067.5M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.02B | $1016.1M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.17B | $1168.1M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.06B | $1056.5M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.03B | $1027.2M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1B | $1001.2M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.09B | $1090.6M | 100% |